18:35 | 29/10/2021 Companies
AstraZeneca Vietnam has recently been recognised with two Vietnam Excellence awards, adding onto the Company’s impressive list of achievements as they celebrate almost three decades of accompanying Vietnam’s health sector.
While Mr. Nitin Kapoor, Chairman and General Director at AstraZeneca Vietnam and Asia Area Frontier Markets, received the Visionary Leader Award, the Company received another important recognition for its Workplace Culture in the HR Excellence category.
Nitin is a British business leader with 25 years of extensive experience across the finance, healthcare and pharmaceutical industries in Europe, Asia-Pacific and the Americas. Since his takeover of AstraZeneca Vietnam in 2018, he has led the Company into a new phase of growth as an industry leader with holistic and meaningful contributions to Vietnam’s health system and economy.
Speaking after the virtual award ceremony, Nitin said: “AstraZeneca Vietnam is honoured to receive these two awards, which are of great encouragement to us as we continue to grow rapidly and contribute meaningfully to both pandemic response and healthcare sector development. People are truly our greatest assets. This recognition belongs to the efforts of all our leadership team members and employees, who have led by example, demonstrated remarkable resilience and creativity on our journey to bring the most values to Vietnamese patients and society."
AstraZeneca Vietnam has successfully transformed its business and strengthened its workplace culture, generating outstanding performances despite industry challenges. The company has championed partnerships with the Vietnamese Government and healthcare partners on various meaningful initiatives to reduce the non-communicable diseases burden and promote sustainability, while supporting the country’s pandemic response with its vaccine supply.
Tran Thi Tuyet Nhung, HR Director, AstraZeneca Vietnam and Asia Area Frontier Markets commented: “We are committed to ensuring that our employees are empowered and inspired to reach their full potential while making a valued contribution to patients and the society. Our top priorities of people strategy are to perform as a single enterprise team, to promote champions of inclusion and diversity and to build a culture of life-long learning and development. People will always play a critical role in AstraZeneca Vietnam’s sustainable growth and successes.”
AstraZeneca Vietnam’s workplace culture is also known to be highly entrepreneurial, innovative, diverse and inclusive. It has been in Anphabe’s Vietnam Top 100 Places to Work since 2018 – a result that is frequently confirmed by its stellar internal survey that is conducted twice a year. With 97% of employees having voted for AstraZeneca Vietnam as a great place to work, the Company has successfully transformed and nurtured its culture to create an ambitious, highly engaged team that is agile and adaptive to stay ahead of the curve.
Always putting patients first, AstraZeneca Vietnam’s efforts were recognised with two award certificates from the Minister of Health in 2019 and 2020 for its contributions to Vietnam’s fight against cancer and COVID-19, and a Medal from the Ho Chi Minh Communist Youth Union for outstanding impact on Vietnamese youths.
Vietnam Excellence is an award programme organised by Anphabe, in coordination with Vietnam Chamber of Commerce and Industry (VCCI), the American Chamber of Commerce in Vietnam (AmCham), European Chamber of Commerce in Vietnam (EuroCham) and the Australian Chamber of Commerce in Vietnam (AusCham) to honour leaders and organisations with excellent achievements in transforming business through talent and workplace development. The outstanding leaders and companies have been selected from three rigorous rounds of selection, from submission appraisal to employee survey, and advisors’ assessment.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.